IDXX Idexx Laboratories Inc

Price (delayed)

$635.15

Market cap

$54.04B

P/E Ratio

74.55

Dividend/share

N/A

EPS

$8.52

Enterprise value

$54.8B

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and ...

Highlights
The company's equity has surged by 174% YoY and by 6% QoQ
The company's EPS has surged by 58% YoY and by 8% QoQ
The quick ratio has decreased by 20% QoQ but it has increased by 19% YoY
IDXX's price to earnings (P/E) is 30% higher than its 5-year quarterly average of 57.5 and 8% higher than its last 4 quarters average of 69.2

Key stats

What are the main financial stats of IDXX
Market
Shares outstanding
85.08M
Market cap
$54.04B
Enterprise value
$54.8B
Valuations
Price to earnings (P/E)
74.55
Price to book (P/B)
72.47
Price to sales (P/S)
17.79
EV/EBIT
63.42
EV/EBITDA
56.86
EV/Sales
17.99
Earnings
Revenue
$3.05B
EBIT
$864.02M
EBITDA
$963.67M
Free cash flow
$694.28M
Per share
EPS
$8.52
Free cash flow per share
$8.14
Book value per share
$8.76
Revenue per share
$35.71
TBVPS
$22.99
Balance sheet
Total assets
$2.41B
Total liabilities
$1.66B
Debt
$993.39M
Equity
$747.46M
Working capital
$349.42M
Liquidity
Debt to equity
1.33
Current ratio
1.54
Quick ratio
0.94
Net debt/EBITDA
0.79
Margins
EBITDA margin
31.6%
Gross margin
58.8%
Net margin
23.9%
Operating margin
28.4%
Efficiency
Return on assets
32.1%
Return on equity
115.4%
Return on invested capital
42.4%
Return on capital employed
49.1%
Return on sales
28.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IDXX stock price

How has the Idexx Laboratories stock price performed over time
Intraday
0.86%
1 week
2.94%
1 month
-4.01%
1 year
50.25%
YTD
27.06%
QTD
2.13%

Financial performance

How have Idexx Laboratories's revenue and profit performed over time
Revenue
$3.05B
Gross profit
$1.79B
Operating income
$863.83M
Net income
$727.85M
Gross margin
58.8%
Net margin
23.9%
The company's net income has surged by 58% YoY and by 8% QoQ
IDXX's operating income is up by 46% YoY and by 8% from the previous quarter
The net margin has grown by 28% YoY
The gross profit has increased by 27% YoY and by 7% QoQ

Growth

What is Idexx Laboratories's growth rate over time

Valuation

What is Idexx Laboratories stock price valuation
P/E
74.55
P/B
72.47
P/S
17.79
EV/EBIT
63.42
EV/EBITDA
56.86
EV/Sales
17.99
The company's EPS has surged by 58% YoY and by 8% QoQ
IDXX's price to earnings (P/E) is 30% higher than its 5-year quarterly average of 57.5 and 8% higher than its last 4 quarters average of 69.2
The company's equity has surged by 174% YoY and by 6% QoQ
The price to book (P/B) is 5% more than the last 4 quarters average of 68.7
The P/S is 80% above the 5-year quarterly average of 9.9 and 16% above the last 4 quarters average of 15.3
IDXX's revenue is up by 23% year-on-year and by 7% since the previous quarter

Efficiency

How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on equity has shrunk by 52% YoY and by 12% QoQ
Idexx Laboratories's return on invested capital has increased by 35% YoY and by 9% QoQ
The return on assets rose by 29% year-on-year and by 2.9% since the previous quarter
The company's return on sales rose by 18% YoY

Dividends

What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDXX.

Financial health

How did Idexx Laboratories financials performed over time
The company's total assets is 45% higher than its total liabilities
The company's total assets rose by 23% YoY and by 3.6% QoQ
The quick ratio has decreased by 20% QoQ but it has increased by 19% YoY
The debt is 33% more than the equity
The company's equity has surged by 174% YoY and by 6% QoQ
IDXX's debt to equity has shrunk by 67% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.